LET Gel 4% — Class II drug recall D-0482-2019
Terminated recall by US Compounding Inc, reported 2019-02-20, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed
| Recall number | D-0482-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | US Compounding Inc, Conway, AR, United States |
| Recall initiated | 2019-01-24 |
| Classified | 2019-02-08 |
| Reported by FDA | 2019-02-20 |
| Terminated | 2020-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 1,931 syringes |
| Reason classes | labeling |
Product
LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0482-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.